Approval for a new saphenous vein graft (svg) indication for the bx velocity stent with raptor over-the-wire (otw) or raptorrail (rx) stent delivery systems (sds).  The device is indicated for the treatment of: patients with symptomatic ischemic heart disease due to discrete de novo or restenotic lesions (<= 30 mm in length) in native coronary arteries with reference diameters ranging from 3.0 mm to 5.0 mm; abrupt or threatened vessel closure in patients with failed interventional therapy in lesions (<= 30 mm in length) with reference diameters in the range of 2.25 mm to 4.00 mm; and,patients with de novo or restenotic saphenous vein graft lesions (<= 30 mm in length) with reference diameters ranging from 3.0 mm to 5.0 mm